Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricing
Additional Novartis medicines will be made available through direct-to-patient platforms in 2026
Company remains committed to investing in markets that value innovation and implement policies that support broad and fast access to medicines
Picard Medical, Inc. / SynCardia Systems LLC commemorate the Company’s transition to the public markets and continued advancement of their Total Artificial Heart technologyContinue reading
Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded three new R01 grants from the National Institutes of Health (NIH), the gold standard of federally funded research awards.Grant funding will advance pediatric lung and spine research.Continue reading
Tucson, AZ –December 15, 2025, NuvOx Therapeutics, Inc. (“NuvOx”) announced that the first patient has been enrolled in the Phase IIb NOVEL trial (NanO2 in Large Vessel Occlusion Stroke (NOVEL): a multicenter single-blind, randomized, placebo-controlled biomarker end point clinical trial of perfluorocarbon in acute ischemic stroke due to large vessel occlusion (LVO).
The NOVEL trial is funded by the Efficacy and Mechanism Evaluation (EME) Program, a partnership between the National Institute for Health Care Research (NIHR) and the Medical Research Council (MRC). The trial is also co-sponsored by the University of Glasgow and NHS Greater Glasgow and Clyde.Continue reading
The University of Arizona College of Medicine – Phoenix and Onvida Health are partnering to launch Arizona’s first rural regional medical school branch. Deeply rooted in community, the partnership will address the severe physician shortage facing the rural regions of the state.Continue reading
Breakthroughs in microbial analysis could enhance disease prediction, environmental protection and our understanding of the planet’s smallest life formsContinue reading
AZBio and members of the Arizona Business and Bioscience Community came together honor Arizona Legislators and State and Local Elected Officials who have made it possible for the Arizona Bioscience Industry to gain national recognition, build capital infrastructure, and take its place as a leader in both scientific discovery and job growth.Continue reading
WASHINGTON, DC (December 2, 2025) – The Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released today its latest biennial report on best practices in bioscience economic development initiatives: The U.S. Bioscience Industry: A Powerful Engine for State Economies.Continue reading
News Release November 24, 2025 – Phoenix, AZ – Today, Governor Katie Hobbs announced the appointment of Debbie Johnston to lead the Arizona Department of Health Services. For the past 21 years, she has worked for the Arizona Hospital and Healthcare Association (AzHHA), focusing on policy development and regulatory affairs. During her tenure at AzHHA, Debbie served on various public health boards and committees at the Arizona Department of Health Services, including the State Trauma Advisory Board and the Arizona Health Improvement Plan Steering Committee. Debbie retired earlier this year as Executive Vice President for the Association.Continue reading